Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Thyroid Cancer, RAI-Refractory

Marcia Brose

MD, PhD

🏢Thomas Jefferson University🌐USA

Professor of Otorhinolaryngology and Head and Neck Surgery

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Marcia Brose is a leading expert in differentiated thyroid cancer and was a principal investigator on the SELECT trial evaluating lenvatinib in RAI-refractory thyroid cancer. Her work has shaped the standard of care for patients who progress beyond radioiodine therapy. She has contributed to understanding resistance mechanisms to kinase inhibitors in thyroid cancer. Her research bridges genomics and clinical outcomes in endocrine malignancies.

Share:

🧪Research Fields 研究领域

differentiated thyroid cancer
lenvatinib
sorafenib
RAI-refractory thyroid
kinase inhibitors

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Marcia Brose 的研究动态

Follow Marcia Brose's research updates

留下邮箱,当我们发布与 Marcia Brose(Thomas Jefferson University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment